EUVIMEDEUVIMED entdecken
Crossref

Plausible Action of N ‐(3,4‐Dimethoxy‐Phenyl)‐6,7‐Dimethoxyquinazoline‐4‐Amine (TKM01) as an Armor Against Alzheimer's Disease: In Silico and In Vivo Insights

Mohd Kashif, Karthikeyan Chandrabose, Ashok Kumar Pandurangan

Journal of Biochemical and Molecular Toxicology · 2024

DOI: 10.1002/jbt.70048 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2024. Verfasst von Mohd Kashif und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, B.S. Abdur Rahman Crescent Institute of Science and Technology, Chennai, India. Hauptthemen laut MEDLINE: Alzheimer Disease, Zebrafish, Molecular Docking Simulation, Quinazolines. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 96 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer's disease (AD) affects millions of people and has limited treatment options, thus making it a global health concern. Amyloid β (Aβ), a disrupted cholinergic system with high acetylcholinesterase (AChE), oxidative stress (OS), reduced antioxidants, and neuroinflammation are key factors influencing AD progression. Prior research has shown that AChE can interact with Aβ and increase its accumulation and neurotoxicity, so targeting AChEs and Aβ could be a potential therapeutic approach for AD treatment. It has been known that nonsteroidal anti‐inflammatory drugs (NSAIDs) can inhibit Aβ accumulation. Previously, TKM01, a derivative of 4‐anilinoquinazoline, has demonstrated inhibitory effects against GSK‐3β—a regulator in AD progression. The current research included molecular docking studies of NSAIDs and TKM01 with Aβ and AChEs as targets. TKM01 exhibited a higher binding affinity with Aβ among all tested compounds. Molecular dynamic (MD) simulations confirmed the stability of the protein‐TKM01 complexes. TKM01 also exhibited favorable drug‐likeness properties, and no hepatoxicity was visualized in comparison with other compounds. Further, in vitro assay showed an inhibitory action of TKM01 (50–1200 µg/mL) on AChEs. In the in vivo studies on zebrafish larvae brains, we found that TKM01 (120 and 240 µg/mL) reduced the levels of AChEs and lipid peroxidation (LPO) and increased antioxidant superoxide dismutase (SOD) and catalase (CAT) in AlCl 3 (80 µM)‐induced AD‐like model. Additionally, TKM01 treatment was found to decrease pro‐inflammatory cytokines TNF‐α, IL‐1β, and IL‐6. The current study demonstrates that TKM01 can be used to treat AD. Nonetheless, experimental validation is needed to reveal the cellular, sub‐cellular, and molecular mechanisms and possible implications at a clinical stage.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseZebrafishMolecular Docking SimulationQuinazolinesAmyloid beta-PeptidesAcetylcholinesteraseAnimalsHumansMolecular Dynamics SimulationCholinesterase InhibitorsOxidative Stress

Stichwörter der Autor:innen

Alzheimer's disease (AD)acetylcholinesterase (AChE)amyloid β (Aβ)molecular dockingmolecular dynamic (MD) simulationneuroinflammationoxidative stress (OS)

Substanzen

QuinazolinesAmyloid beta-PeptidesAcetylcholinesteraseCholinesterase Inhibitors

Autor:innen und Institutionen

  • School of Life Sciences, B.S. Abdur Rahman Crescent Institute of Science and Technology, Chennai, India.
  • Department of Pharmacy, Indira Gandhi National Tribal University, Amarkantak, Madhya Pradesh, India.

Zitieren

APA

Kashif, M., Chandrabose, K., & Pandurangan, A. K. (2024). Plausible Action of N ‐(3,4‐Dimethoxy‐Phenyl)‐6,7‐Dimethoxyquinazoline‐4‐Amine (TKM01) as an Armor Against Alzheimer's Disease: In Silico and In Vivo Insights. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.70048

Vancouver

Kashif M, Chandrabose K, Pandurangan AK. Plausible Action of N ‐(3,4‐Dimethoxy‐Phenyl)‐6,7‐Dimethoxyquinazoline‐4‐Amine (TKM01) as an Armor Against Alzheimer's Disease: In Silico and In Vivo Insights. Journal of Biochemical and Molecular Toxicology. 2024. doi:10.1002/jbt.70048

BibTeX
@article{Kashif2024,
  author = {Kashif, Mohd and Chandrabose, Karthikeyan and Pandurangan, Ashok Kumar},
  title = {Plausible Action of N ‐(3,4‐Dimethoxy‐Phenyl)‐6,7‐Dimethoxyquinazoline‐4‐Amine (TKM01) as an Armor Against Alzheimer's Disease: In Silico and In Vivo Insights},
  journal = {Journal of Biochemical and Molecular Toxicology},
  year = {2024},
  doi = {10.1002/jbt.70048}
}
Kostenlos starten →